Differences in interpretation of haemoglobin A1c values among diabetes care professionals

Netherlands Journal of Medicine

Volumn 72, Issue 9, 2014, Pages 462-466

  Lenters Westra, E ^a,b   Schindhelm, R K ^c   Bilo, H J G ^a,d   Groenier, K H ^d,e   Slingerland, R J ^a,b  

^a Isala Hospitals   (Netherlands)

^b European Reference Laboratory for Glycohaemoglobin   (Netherlands)

^c Location Alkmaar   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ISALA HOSPITAL   (Netherlands)

Author keywords

Glycated haemoglobin; Healthcare professionals; Interpretation; Nurses; Physicians

Indexed keywords

HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; BLOOD GLUCOSE MONITORING; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HUMAN; QUESTIONNAIRE; TREATMENT RESPONSE; BLOOD; CLINICAL PRACTICE; METABOLISM; NURSING PRACTICE;

DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PRACTICE PATTERNS, NURSES'; PRACTICE PATTERNS, PHYSICIANS'; SURVEYS AND QUESTIONNAIRES;

EID: 84938080533     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. American Diabetes Association. Standards of medical care in diabetes – 2014. Diabetes Care. 2014;37:S14-S80.
2. Lenters-Westra E, Schindhelm RK, Bilo HJ, Slingerland RJ. Haemoglobin A1c: historical overview and current concepts. Diabetes Res Clin Pract. 2013;99:75-84.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53.
5. Schindhelm RK, Lenters-Westra E, Slingerland RJ. Glycated haemoglobin A(1c) (HbA(1c)) in the diagnosis of diabetes mellitus: don’t forget the performance of the HbA(1c) assay. Diabet Med. 2013;27:1214-5.
6. Lenters-Westra E, Weykamp CW, Schindhelm RK, Siebelder C, Bilo HJ, Slingerland RJ. One in five laboratories using various Hemoglobin A1c methods do not meet the criteria for optimal diabetes care management. Diab Tech Ther. 2011;213:429-33.
7. Dutch College of General Practitioners (NHG). M01 NHG-Standaard Diabetes Mellitus type 2 [in Dutch]. Huisarts Wetenschap. 2006;7:137-52.
8. Skeie S, Thue G, Sandberg S. Use and interpretation of HbA1c testing in general practice. Implications for quality of care. Scand J Clin Lab Invest. 2000;60:349-56.
9. Hortensius J, Kleefstra N, Houweling ST, van der Bijl JJ, Gans RO, Bilo HJ. What do professionals recommend regarding the frequency of self-monitoring of blood glucose? Neth J Med. 2012;70:287-91.
10. Landman GW, Hateren KJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11). Br J Gen Pract. 2010;60:172-5.
11. Graffy J. Tailoring treatment to risk in type 2 diabetes. Br J Gen Pract. 2010;60:158-60.
12. Logtenberg SJJ, Kleefstra N, Ubink-Veltmaat LJ, Houweling ST, Bilo HJG. Glucoseregulatie Type 2 diabetes mellitus bij ketenzorg anno 2005 (ZODIAC-7) [in Dutch]. Ned Tijdschr Diabetologie. 2007;5:15-8.
13. Omar F, van der Watt GF, Pillay TS. Reference change values: how useful are they? J Clin Pathol. 2008;61:426-7.
14. Ricos C, Cava F, Garcia-Lario JV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest. 2004;64:175-84.
15. Weykamp CW, Lenters-Westra E, Van der Vuurst H, Slingerland RJ, Siebelder C, Visser-Dekker W. Evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser for HbA1c. Clin Chem Lab Med. 2011;49:647-51.